US Patent Issued to SRI International on March 17 for "Peptide saporin conjugate for the treatment of cancer" (Virginia, California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,157, issued on March 17, was assigned to SRI International (Menlo Park, Calif.).

"Peptide saporin conjugate for the treatment of cancer" was invented by Kathlynn C. Brown (Staunton, Va.), Curtis Allred (Menlo Park, Calif.) and Michael McGuire (Harrisonburg, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein, are compositions comprising one or more a molecular guidance system (MGS) peptides and a cytotoxic agent. Also described herein, are methods of administering the compositions to patients with cancer."

The patent was filed on July 14, 2023, under Application No. 18/352,791.

*For further information, including images, charts an...